查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1750886

球体市场规模、份额、趋势分析报告：按类型、方法、来源、应用、最终用途、地区、细分市场预测，2025-2030 年

Spheroids Market Size, Share & Trends Analysis Report By Type, By Method, By Source, By Application (Developmental Biology, Personalized Medicine, Regenerative Medicine), By End Use, By Region And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

球体市场的成长与趋势：

根据 Grand View Research, Inc. 的最新报告，全球球状体市场规模预计到 2030 年将达到 24.6 亿美元，2025 年至 2030 年的复合年增长率为 22.7%。

由于对先进的3D细胞培养模型的需求日益增长，该市场正获得显着发展，因为这种模型比传统的2D培养提供了更符合生理学的条件。球状体能够更好地模拟细胞结构、营养梯度和体内组织微环境，并在药物筛检、疾病建模、毒性测试和再生医学领域中得到越来越广泛的应用。它们的应用涵盖了广泛的治疗领域，包括肿瘤学、神经病学和代谢疾病，因为研发和製药公司优先考虑更精确的临床前模型，以提高药物开发的成功率并减少后期失败。

另一个主要驱动因素是将球体纳入高通量筛检(HTS) 系统，这使得製药和生物技术公司能够评估具有更高预测值的大型化合物库。低黏附板、悬滴系统和微流体平台等新工具和技术的开发也推动了市场的发展，这些技术简化了球体的生产并提高了可重复性。此外，政府机构和私人投资者的资金投入不断增加，也支持了 3D 培养研究在学术和商业性领域的扩展。

COVID-19 疫情进一步加速了细胞球模型的应用，尤其是在病毒学和免疫学研究中。随着研究人员寻求更接近人体组织的模型，细胞球已被证明在研究 SARS-CoV-2 感染机制、宿主免疫反应和抗病毒药物疗效方面大有裨益。疫情凸显了传统二维培养和动物模型在快速理解复杂疾病方面的局限性，促使人们增加了对包括细胞球在内的 3D 培养技术的投资。这种转变也支持了市场的长期成长，因为实验室纷纷采用先进的培养系统来巩固其未来的研究基础。

即使疫情过后，由于全球都在努力推行更符合伦理、更有效率的临床前测试策略，球状体市场仍保持强劲成长动能。监管机构和研究机构越来越认识到球状体和其他3D模型在减少动物试验和提升转化效果的价值。此外，个人化医疗的兴起以及利用患者来源细胞製备针对特异性疾病的球状体，为定製药物开发和治疗测试开闢了新的机会。这些因素共同推动了球状体市场在未来几年的强劲成长。

球体市场报告重点

  • 多细胞肿瘤球体 (MCTS) 细分市场预计将在 2024 年占据最大的收益占有率，达到 28.91%，并有望在预测期内以最快的速度成长。 MCTS 能够忠实地再现体内肿瘤微环境，从而实现更精准的癌症研究和药物筛检。其模拟肿瘤异质性和抗药性的能力正推动其在肿瘤学研究中的应用。
  • 吊挂滴技术预计将在2024年占据最大的收益占有率，达到31.34%，并有望在预测期内实现最快的成长率。这项简单且经济高效的技术无需支架即可形成均匀的球体，使其成为可控实验装置的理想选择。其易用性以及与高通量系统的兼容性使其在研究中广泛应用。
  • 细胞株係部分在 2024 年占据了 56.64% 的显着收益占有率。细胞株係是主要的市场驱动力，因为它们提供了标准化、可重复且经济高效的资源，可用于产生广泛研究应用的 3D 球体模型。
  • 再生医学领域预计将在预测期内实现最高的复合年增长率。球状体透过促进细胞间相互作用和模拟天然组织结构来增强组织工程。球状体在开发功能性组织结构方面的作用在再生疗法中至关重要。
  • 2024年，生物技术和製药产业占了最大的收益占有率，达到46.33%。这些行业利用球体进行预测毒理学、疗效筛检和疾病建模。对可扩展、与人体相关的3D模型的需求正在推动其融入开发平臺。
  • 北美凭藉其完善的法律规范和医疗保健基础设施占据市场主导地位，这有助于基于球体的产品的临床应用和采用，进一步推动市场成长。
  • 赛默飞世尔科技公司、康宁公司、默克公司、龙沙公司、InSphero AG、Greiner Bio-One International GmbH、3D Biotek LLC、CN Bio Innovations、可乐丽公司。

目录

第一章调查方法与范围

第二章执行摘要

第三章 球体市场变数与趋势

  • 市场展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 球体市场分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19影响分析

第四章 业务类型分析

  • 细分仪表板
  • 全球球体市场：类型变异分析
  • 全球球体市场规模及趋势分析（按类型，2018-2030）
  • 多细胞肿瘤球体（MCTS）
  • 神经球
  • 乳球体
  • 肝球
  • 胚胎样状体

第五章 依方法论进行的商业分析

  • 细分仪表板
  • 全球球体市场：方法论变异分析
  • 全球球体市场规模及趋势分析（依方法，2018-2030）
  • 微图案板
  • 低细胞附着板
  • 悬滴法
  • 其他的

第六章 供应源业务分析

  • 细分仪表板
  • 全球球状体市场：来源变异分析
  • 全球球体市场规模与趋势分析（按来源）（2018-2030 年）
  • 细胞株
  • 初代细胞
  • iPSC衍生细胞

第七章 按最终用途分類的业务分析

  • 细分仪表板
  • 全球球体市场：最终用途差异分析
  • 全球球体市场规模与趋势分析（依最终用途，2018-2030 年）
  • 生物技术和製药业
  • 学术研究所
  • 医院和诊断中心

第 8 章 按应用程式进行业务分析

  • 细分仪表板
  • 全球球体市场：应用趋势分析
  • 全球球体市场规模及趋势分析（按应用，2018-2030）
  • 发育生物学
  • 个人化医疗
  • 再生医学
  • 疾病病理学研究
  • 药物毒性和疗效研究

第九章区域业务分析（按国家、按类型、按方法、按来源、按应用和按最终用途）

  • 细分仪表板
  • 2018年至2030年市场规模、预测与趋势分析
  • 北美洲
    • 2018-2030年北美市场估计与预测
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018-2030年欧洲市场估计与预测
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018-2030年亚太市场估计与预测
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 2018-2030年拉丁美洲市场估计与预测
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 2018-2030年MEA市场预测及预测
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 科威特

第十章 竞争格局

  • 公司分类
  • 战略地图
  • 2024年企业地位分析
  • 公司简介/列表
    • Thermo Fisher Scientific, Inc.
    • Merck KGaA
    • Lonza
    • CN Bio Innovations
    • 3D Biotek LLC
    • Kuraray Co., Ltd.
    • Tecan Group Ltd.
    • Corning Incorporated
    • Greiner Bio-One
    • InSphero
Product Code: GVR-4-68040-562-8

Spheroids Market Growth & Trends:

The global spheroids market size is expected to reach USD 2.46 billion by 2030 and is anticipated to grow at a CAGR of 22.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market has gained significant traction due to the growing demand for advanced 3D cell culture models that offer more physiologically relevant conditions than traditional 2D cultures. Spheroids, which better mimic the cellular architecture, nutrient gradients, and microenvironment of tissues in vivo, are increasingly used in drug screening, disease modeling, toxicology testing, and regenerative medicine. Their application spans a wide range of therapeutic areas, including oncology, neurology, and metabolic diseases, as researchers and pharmaceutical companies prioritize more accurate preclinical models to improve drug development success rates and reduce late-stage failures.

Another major driver is the integration of spheroids into high-throughput screening (HTS) systems, enabling pharmaceutical and biotechnology companies to evaluate large compound libraries with greater predictive value. The market is also fueled by developing novel tools and technologies such as low-attachment plates, hanging drop systems, and microfluidic platforms that simplify spheroid generation and improve reproducibility. In addition, increased funding from government agencies and private investors has supported the expansion of 3D culture research in academic and commercial settings.

The COVID-19 pandemic further accelerated the adoption of spheroid models, particularly in virology and immunology research. As researchers sought models that more closely represented human tissues, spheroids proved valuable for studying SARS-CoV-2 infection mechanisms, host immune responses, and antiviral drug efficacy. The pandemic highlighted the limitations of conventional 2D cultures and animal models in rapidly understanding complex diseases, leading to increased investment in 3D culture technologies, including spheroids. This shift also supported long-term market growth as laboratories increasingly adopted advanced culture systems to future-proof research infrastructure.

Post-pandemic, the momentum around spheroids has continued, driven by a global push toward more ethical and efficient preclinical testing strategies. Regulatory agencies and research institutions increasingly recognize the value of spheroids and other 3D models in reducing animal testing while improving translational outcomes. Furthermore, the rise of personalized medicine and the use of patient-derived cells to form disease-specific spheroids are opening new opportunities for customized drug development and therapeutic testing. Together, these factors are shaping a robust outlook for the market in the years ahead.

Spheroids Market Report Highlights:

  • The multicellular tumor spheroids (MCTS) segment accounted for the largest revenue share of 28.91% in 2024 and is expected to have the fastest growth rate over the forecast period. MCTS closely replicates the in vivo tumor microenvironment, enabling more accurate cancer research and drug screening. Their ability to model tumor heterogeneity and drug resistance drives their adoption in oncology-focused studies.
  • The hanging drop method segment accounted for the largest revenue share of 31.34% in 2024 and is expected to have the fastest growth rate over the forecast period. This simple and cost-effective technique facilitates uniform spheroid formation without scaffolds, ideal for controlled experimental setups. Its ease of use and compatibility with high-throughput systems support widespread research adoption.
  • The cell line segment accounted for a larger revenue share of 56.64% in 2024. Cell lines are a major market driver because they provide a standardized, reproducible, and cost-effective resource for generating 3D spheroid models across a wide range of research applications.
  • The regenerative medicine segment is expected to witness the highest CAGR over the forecast period. Spheroids enhance tissue engineering by promoting cell-cell interactions and mimicking native tissue structures. Their role in developing functional tissue constructs makes them essential in regenerative therapies.
  • The biotechnology and pharmaceutical industries segment accounted for the largest revenue share of 46.33% in 2024. These industries utilize spheroids for predictive toxicology, efficacy screening, and disease modeling. The demand for human-relevant, scalable 3D models drives their integration into R&D pipelines.
  • North America dominated the market due to its well-established regulatory frameworks and healthcare infrastructure. These facilitate the clinical translation and adoption of spheroid-based products, further propelling market growth.
  • Thermo Fisher Scientific Inc., Corning Incorporated, Merck KGaA, Lonza, InSphero AG, Greiner Bio-One International GmbH, 3D Biotek LLC, CN Bio Innovations, Kuraray Co., Ltd., and Tecan Group Ltd. are some of the market players operating in the market.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Method
    • 1.1.3. Source
    • 1.1.4. Application
    • 1.1.5. End Use
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Spheroids Market Variables and Trends

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. High adoption of spheroids in drug discovery
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. Rising demand for tissue engineering & organ transplantation
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Challenges associated with 3D cell culturing
      • 3.2.2.2. Ethical issues associated with spheroid cultures
  • 3.3. Spheroids Market Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Type Business Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Spheroids Market: Type Movement Analysis
  • 4.3. Global Spheroids Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Multicellular tumor spheroids (MCTS)
    • 4.4.1. MCTS market estimates and forecast, 2018 - 2030
  • 4.5. Neurospheres
    • 4.5.1. Neurospheres market estimates and forecast, 2018 - 2030
  • 4.6. Mammospheres
    • 4.6.1. Mammospheres market estimates and forecast, 2018 - 2030
  • 4.7. Hepatospheres
    • 4.7.1. Hepatospheres market estimates and forecast, 2018 - 2030
  • 4.8. Embryoid bodies
    • 4.8.1. Embryoid bodies market estimates and forecast, 2018 - 2030

Chapter 5. Method Business Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Spheroids Market: Method Movement Analysis
  • 5.3. Global Spheroids Market Size & Trend Analysis, by Method, 2018 to 2030 (USD Million)
  • 5.4. Micropatterned Plates
    • 5.4.1. Micropatterned plates market estimates and forecast, 2018 - 2030
  • 5.5. Low Cell Attachment Plates
    • 5.5.1. Low cell attachment plates market estimates and forecast, 2018 - 2030
  • 5.6. Hanging Drop Method
    • 5.6.1. Hanging drop method market estimates and forecast, 2018 - 2030
  • 5.7. Others
    • 5.7.1. Other methods market estimates and forecast, 2018 - 2030

Chapter 6. Source Business Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Spheroids Market: Source Movement Analysis
  • 6.3. Global Spheroids Market Size & Trend Analysis, by Source, 2018 to 2030 (USD Million)
  • 6.4. Cell Line
    • 6.4.1. Cell line market estimates and forecast, 2018 - 2030
  • 6.5. Primary Cell
    • 6.5.1. Primary cell market estimates and forecast, 2018 - 2030
  • 6.6. iPSCs Derived Cells
    • 6.6.1. iPSCs derived cells market estimates and forecast, 2018 - 2030

Chapter 7. End Use Business Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Spheroids Market: End Use Movement Analysis
  • 7.3. Global Spheroids Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.4. Biotechnology and Pharmaceutical Industries
    • 7.4.1. Biotechnology and pharmaceutical industries market estimates and forecast 2018 to 2030, (USD million)
  • 7.5. Academic & Research Institutes
    • 7.5.1. Academic & research institutes market estimates and forecast 2018 to 2030, (USD Million)
  • 7.6. Hospitals and Diagnostic Centers
    • 7.6.1. Hospitals and diagnostic centers market estimates and forecast 2018 to 2030, (USD million)

Chapter 8. Application Business Analysis

  • 8.1. Segment Dashboard
  • 8.2. Global Spheroids Market: Application Movement Analysis
  • 8.3. Global Spheroids Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 8.4. Developmental Biology
    • 8.4.1. Developmental biology market estimates and forecast 2018 to 2030, (USD million)
  • 8.5. Personalized Medicine
    • 8.5.1. Personalized medicine market estimates and forecast 2018 to 2030, (USD Million)
  • 8.6. Regenerative Medicine
    • 8.6.1. Regenerative medicine market estimates and forecast 2018 to 2030, (USD million)
  • 8.7. Disease Pathology Studies
    • 8.7.1. Disease pathology studies market estimates and forecast 2018 to 2030, (USD Million)
  • 8.8. Drug Toxicity & Efficacy Testing
    • 8.8.1. Drug toxicity & efficacy testing market estimates and forecast 2018 to 2030, (USD Million)

Chapter 9. Regional Business Analysis, by Country, Type, Method, Source, Application, & End Use

  • 9.1. Segment Dashboard
  • 9.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 9.3. North America
    • 9.3.1. North America market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.3.2. U.S.
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Target Disease Prevalence
      • 9.3.2.3. Competitive Scenario
      • 9.3.2.4. U.S. Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.3.3. Canada
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Target Disease Prevalence
      • 9.3.3.3. Competitive Scenario
      • 9.3.3.4. Canada Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.3.4. Mexico
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Target Disease Prevalence
      • 9.3.4.3. Competitive Scenario
      • 9.3.4.4. Mexico Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 9.4. Europe
    • 9.4.1. Europe Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.4.2. UK
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Target Disease Prevalence
      • 9.4.2.3. Competitive Scenario
      • 9.4.2.4. UK Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.4.3. Germany
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Target Disease Prevalence
      • 9.4.3.3. Competitive Scenario
      • 9.4.3.4. Germany Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.4.4. France
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Target Disease Prevalence
      • 9.4.4.3. Competitive Scenario
      • 9.4.4.4. France Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.4.5. Italy
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Target Disease Prevalence
      • 9.4.5.3. Competitive Scenario
      • 9.4.5.4. Italy Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.4.6. Spain
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Target Disease Prevalence
      • 9.4.6.3. Competitive Scenario
      • 9.4.6.4. Spain Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.4.7. Denmark
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Target Disease Prevalence
      • 9.4.7.3. Competitive Scenario
      • 9.4.7.4. Denmark Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.4.8. Sweden
      • 9.4.8.1. Key Country Dynamics
      • 9.4.8.2. Target Disease Prevalence
      • 9.4.8.3. Competitive Scenario
      • 9.4.8.4. Sweden Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.4.9. Norway
      • 9.4.9.1. Key Country Dynamics
      • 9.4.9.2. Target Disease Prevalence
      • 9.4.9.3. Competitive Scenario
      • 9.4.9.4. Norway Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 9.5. Asia Pacific
    • 9.5.1. Asia Pacific Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.5.2. China
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Target Disease Prevalence
      • 9.5.2.3. Competitive Scenario
      • 9.5.2.4. China Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.5.3. Japan
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Target Disease Prevalence
      • 9.5.3.3. Competitive Scenario
      • 9.5.3.4. Japan Market estimates and forecast, 2018 - 2030 (Volume, Thousand)
    • 9.5.4. India
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Target Disease Prevalence
      • 9.5.4.3. Competitive Scenario
      • 9.5.4.4. India Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.5.5. Australia
      • 9.5.5.1. Key Country Dynamics
      • 9.5.5.2. Target Disease Prevalence
      • 9.5.5.3. Competitive Scenario
      • 9.5.5.4. Australia Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.5.6. Thailand
      • 9.5.6.1. Key Country Dynamics
      • 9.5.6.2. Target Disease Prevalence
      • 9.5.6.3. Competitive Scenario
      • 9.5.6.4. Thailand Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.5.7. South Korea
      • 9.5.7.1. Key Country Dynamics
      • 9.5.7.2. Target Disease Prevalence
      • 9.5.7.3. Competitive Scenario
      • 9.5.7.4. South Korea Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 9.6. Latin America
    • 9.6.1. Latin America Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.6.2. Brazil
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Target Disease Prevalence
      • 9.6.2.3. Competitive Scenario
      • 9.6.2.4. Brazil Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.6.3. Argentina
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Target Disease Prevalence
      • 9.6.3.3. Competitive Scenario
      • 9.6.3.4. Argentina Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 9.7. MEA
    • 9.7.1. MEA Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.7.2. Saudi Arabia
      • 9.7.2.1. Key Country Dynamics
      • 9.7.2.2. Target Disease Prevalence
      • 9.7.2.3. Competitive Scenario
      • 9.7.2.4. Saudi Arabia Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.7.3. South Africa
      • 9.7.3.1. Key Country Dynamics
      • 9.7.3.2. Target Disease Prevalence
      • 9.7.3.3. Competitive Scenario
      • 9.7.3.4. South Africa Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.7.4. UAE
      • 9.7.4.1. Key Country Dynamics
      • 9.7.4.2. Target Disease Prevalence
      • 9.7.4.3. Competitive Scenario
      • 9.7.4.4. UAE Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 9.7.5. Kuwait
      • 9.7.5.1. Key Country Dynamics
      • 9.7.5.2. Target Disease Prevalence
      • 9.7.5.3. Competitive Scenario
      • 9.7.5.4. Kuwait Market estimates and forecast, 2018 - 2030 (USD Billion)

Chapter 10. Competitive Landscape

  • 10.1. Company Categorization
  • 10.2. Strategy Mapping
  • 10.3. Company Position Analysis, 2024
  • 10.4. Company Profiles/Listing
    • 10.4.1. Thermo Fisher Scientific, Inc.
      • 10.4.1.1. Company overview
      • 10.4.1.2. Financial performance
      • 10.4.1.3. Product benchmarking
      • 10.4.1.4. Strategic initiatives
    • 10.4.2. Merck KGaA
      • 10.4.2.1. Company overview
      • 10.4.2.2. Financial performance
      • 10.4.2.3. Product benchmarking
      • 10.4.2.4. Strategic initiatives
    • 10.4.3. Lonza
      • 10.4.3.1. Company overview
      • 10.4.3.2. Financial performance
      • 10.4.3.3. Product benchmarking
      • 10.4.3.4. Strategic initiatives
    • 10.4.4. CN Bio Innovations
      • 10.4.4.1. Company overview
      • 10.4.4.2. Financial performance
      • 10.4.4.3. Product benchmarking
      • 10.4.4.4. Strategic initiatives
    • 10.4.5. 3D Biotek LLC
      • 10.4.5.1. Company overview
      • 10.4.5.2. Financial performance
      • 10.4.5.3. Product benchmarking
      • 10.4.5.4. Strategic initiatives
    • 10.4.6. Kuraray Co., Ltd.
      • 10.4.6.1. Company overview
      • 10.4.6.2. Financial performance
      • 10.4.6.3. Product benchmarking
      • 10.4.6.4. Strategic initiatives
    • 10.4.7. Tecan Group Ltd.
      • 10.4.7.1. Company overview
      • 10.4.7.2. Financial performance
      • 10.4.7.3. Product benchmarking
      • 10.4.7.4. Strategic initiatives
    • 10.4.8. Corning Incorporated
      • 10.4.8.1. Company overview
      • 10.4.8.2. Financial performance
      • 10.4.8.3. Product benchmarking
      • 10.4.8.4. Strategic initiatives
    • 10.4.9. Greiner Bio-One
      • 10.4.9.1. Company overview
      • 10.4.9.2. Financial performance
      • 10.4.9.3. Product benchmarking
      • 10.4.9.4. Strategic initiatives
    • 10.4.10. InSphero
      • 10.4.10.1. Company overview
      • 10.4.10.2. Financial performance
      • 10.4.10.3. Product benchmarking
      • 10.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 3 North America spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 4 North America spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 5 North America spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 6 North America spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 7 North America spheroids market, by region, 2018 - 2030 (USD Million)
  • Table 8 U.S. spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 9 U.S. spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 10 U.S. spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 11 U.S. spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 12 U.S. spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 13 Canada spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 14 Canada spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 15 Canada spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 16 Canada spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 17 Canada spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 18 Mexico spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 19 Mexico spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 20 Mexico spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 21 Mexico spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 22 Mexico spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 23 Europe spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 24 Europe spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 25 Europe spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 26 Europe spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 27 Europe spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 28 Europe spheroids market, by region, 2018 - 2030 (USD Million)
  • Table 29 Germany spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 30 Germany spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 31 Germany spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 32 Germany spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 33 Germany spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 34 UK spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 35 UK spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 36 UK spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 37 UK spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 38 UK spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 39 France spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 40 France spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 41 France spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 42 France spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 43 France spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 44 Italy spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 45 Italy spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 46 Italy spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 47 Italy spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 48 Italy spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 49 Spain spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 50 Spain spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 51 Spain spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 52 Spain spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 53 Spain spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 54 Sweden spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 55 Sweden spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 56 Sweden spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 57 Sweden spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 58 Sweden spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 59 Norway spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 60 Norway spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 61 Norway spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 62 Norway spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 63 Norway spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 64 Denmark spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 65 Denmark spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 66 Denmark spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 67 Denmark spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 68 Denmark spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 69 APAC spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 70 APAC spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 71 APAC spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 72 APAC spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 73 APAC spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 74 APAC spheroids market, by region, 2018 - 2030 (USD Million)
  • Table 75 China spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 76 China spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 77 China spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 78 China spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 79 China spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 80 Japan spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 81 Japan spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 82 Japan spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 83 Japan spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 84 Japan spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 85 India spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 86 India spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 87 India spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 88 India spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 89 India spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 90 Thailand spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 91 Thailand spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 92 Thailand spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 93 Thailand spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 94 Thailand spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 95 South Korea spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 96 South Korea spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 97 South Korea spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 98 South Korea spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 99 South Korea spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 100 Australia spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 101 Australia spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 102 Australia spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 103 Australia spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 104 Australia spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 105 Latin America spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 106 Latin America spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 107 Latin America spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 108 Latin America spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 109 Latin America spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 110 Latin America spheroids market, by region, 2018 - 2030 (USD Million)
  • Table 111 Brazil spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 112 Brazil spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 113 Brazil spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 114 Brazil spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 115 Brazil spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 116 Argentina spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 117 Argentina spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 118 Argentina spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 119 Argentina spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 120 Argentina spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 121 Middle East and Africa spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 122 Middle East and Africa spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 123 Middle East and Africa spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 124 Middle East and Africa spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 125 Middle East and Africa spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 126 Middle East and Africa spheroids market, by region, 2018 - 2030 (USD Million)
  • Table 127 South Africa spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 128 South Africa spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 129 South Africa spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 130 South Africa spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 131 South Africa spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 132 Saudi Arabia spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 133 Saudi Arabia spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 134 Saudi Arabia spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 135 Saudi Arabia spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 136 Saudi Arabia spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 137 UAE spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 138 UAE spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 139 UAE spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 140 UAE spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 141 UAE spheroids market, by application, 2018 - 2030 (USD Million)
  • Table 142 Kuwait spheroids market, by type, 2018 - 2030 (USD Million)
  • Table 143 Kuwait spheroids market, by method, 2018 - 2030 (USD Million)
  • Table 144 Kuwait spheroids market, by source, 2018 - 2030 (USD Million)
  • Table 145 Kuwait spheroids market, by End Use, 2018 - 2030 (USD Million)
  • Table 146 Kuwait spheroids market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Spheroids: market outlook
  • Fig. 9 Spheroids competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Spheroids market driver impact
  • Fig. 13 Spheroids market restraint impact
  • Fig. 14 Spheroids market strategic initiatives analysis
  • Fig. 15 Spheroids market: type movement analysis
  • Fig. 16 Spheroids market: type outlook and key takeaways
  • Fig. 17 MCTS market estimates and forecast, 2018 - 2030
  • Fig. 18 Neurospheres market estimates and forecast, 2018 - 2030
  • Fig. 19 Mammospheres market estimates and forecast, 2018 - 2030
  • Fig. 20 Hepatospheres market estimates and forecast, 2018 - 2030
  • Fig. 21 Embryoid bodies market estimates and forecast, 2018 - 2030
  • Fig. 22 Spheroids market: method movement analysis
  • Fig. 23 Spheroids market: method outlook and key takeaways
  • Fig. 24 Micropatterned plates market estimates and forecast, 2018 - 2030
  • Fig. 25 Low cell attachment plates market estimates and forecast, 2018 - 2030
  • Fig. 26 Hanging drop method for spheroid culture market estimates and forecast, 2018 - 2030
  • Fig. 27 Other methods for spheroid culture market estimates and forecast, 2018 - 2030
  • Fig. 28 Spheroids market: source movement analysis
  • Fig. 29 Spheroids market: source outlook and key takeaways
  • Fig. 30 Cell line market estimates and forecast, 2018 - 2030
  • Fig. 31 Primary cell market estimates and forecast, 2018 - 2030
  • Fig. 32 iPSCs derived cells market estimates and forecast, 2018 - 2030
  • Fig. 33 Spheroids market: End Use movement analysis
  • Fig. 34 Spheroids market: End Use outlook and key takeaways
  • Fig. 35 Biotechnology and pharmaceutical industries market estimates and forecast, 2018- 2030
  • Fig. 36 Academic & research institutes market estimates and forecast, 2018 - 2030
  • Fig. 37 Hospitals and diagnostic centers market estimates and forecast, 2018 - 2030
  • Fig. 38 Spheroids market: application movement analysis
  • Fig. 39 Spheroids market: application outlook and key takeaways
  • Fig. 40 Developmental biology market estimates and forecast, 2018 - 2030
  • Fig. 41 Personalized medicine market estimates and forecast, 2018 - 2030
  • Fig. 42 Regenerative medicine market estimates and forecast, 2018 - 2030
  • Fig. 43 Disease pathology studies market estimates and forecast, 2018 - 2030
  • Fig. 44 Drug toxicity & efficacy testing market estimates and forecast, 2018 - 2030
  • Fig. 45 Global Spheroids market: regional movement analysis
  • Fig. 46 Global Spheroids market: regional outlook and key takeaways
  • Fig. 47 North America
  • Fig. 48 North America market estimates and forecast, 2018 - 2030
  • Fig. 49 U.S. key country dynamics
  • Fig. 50 U.S. market estimates and forecast, 2018 - 2030
  • Fig. 51 Canada key country dynamics
  • Fig. 52 Canada market estimates and forecast, 2018 - 2030
  • Fig. 53 Mexico key country dynamics
  • Fig. 54 Mexico market estimates and forecast, 2018 - 2030
  • Fig. 55 Europe
  • Fig. 56 Europe. market estimates and forecast, 2018 - 2030
  • Fig. 57 UK key country dynamics
  • Fig. 58 UK market estimates and forecast, 2018 - 2030
  • Fig. 59 Germany key country dynamics
  • Fig. 60 Germany market estimates and forecast, 2018 - 2030
  • Fig. 61 France key country dynamics
  • Fig. 62 France market estimates and forecast, 2018 - 2030
  • Fig. 63 Italy key country dynamics
  • Fig. 64 Italy market estimates and forecast, 2018 - 2030
  • Fig. 65 Spain key country dynamics
  • Fig. 66 Spain market estimates and forecast, 2018 - 2030
  • Fig. 67 Sweden key country dynamics
  • Fig. 68 Sweden market estimates and forecast, 2018 - 2030
  • Fig. 69 Norway key country dynamics
  • Fig. 70 Norway market estimates and forecast, 2018 - 2030
  • Fig. 71 Denmark key country dynamics
  • Fig. 72 Denmark market estimates and forecast, 2018 - 2030
  • Fig. 73 Asia Pacific
  • Fig. 74 Asia Pacific market estimates and forecast, 2018 - 2030
  • Fig. 75 China key country dynamics
  • Fig. 76 China market estimates and forecast, 2018 - 2030
  • Fig. 77 Japan key country dynamics
  • Fig. 78 Japan market estimates and forecast, 2018 - 2030
  • Fig. 79 India key country dynamics
  • Fig. 80 India market estimates and forecast, 2018 - 2030
  • Fig. 81 Australia key country dynamics
  • Fig. 82 Australia market estimates and forecast, 2018 - 2030
  • Fig. 83 Thailand key country dynamics
  • Fig. 84 Thailand market estimates and forecast, 2018 - 2030
  • Fig. 85 South Korea key country dynamics
  • Fig. 86 South Korea market estimates and forecast, 2018 - 2030
  • Fig. 87 Latin America
  • Fig. 88 Latin America market estimates and forecast, 2018 - 2030
  • Fig. 89 Brazil key country dynamics
  • Fig. 90 Brazil market estimates and forecast, 2018 - 2030
  • Fig. 91 Argentina key country dynamics
  • Fig. 92 Argentina market estimates and forecast, 2018 - 2030
  • Fig. 93 Middle East and Africa
  • Fig. 94 Middle East and Africa. market estimates and forecast, 2018 - 2030
  • Fig. 95 Saudi Arabia key country dynamics
  • Fig. 96 Saudi Arabia market estimates and forecast, 2018 - 2030
  • Fig. 97 South Africa key country dynamics
  • Fig. 98 South Africa market estimates and forecast, 2018 - 2030
  • Fig. 99 UAE key country dynamics
  • Fig. 100 UAE market estimates and forecast, 2018 - 2030
  • Fig. 101 Kuwait key country dynamics
  • Fig. 102 Kuwait market estimates and forecast, 2018 - 2030